Zawamedsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-01-15
Share capital
100 000,00 PLN
Activity description

Zawamed is a company that conducts preclinical and clinical research, as well as training using in vitro models. They support clients in various industries, including cosmetics, feed, food, and pharmaceuticals, by assisting with funding acquisition, study design, execution, result interpretation, and report creation. Additionally, they provide services related to clinical trial cost settlements and patient compensation.

Registered address
ul. Marii Rodziewiczówny 9, 07-300 Ostrów Mazowiecka, Poland
Website
zawamed.plWebsite active
Email
Email warning
Phone
Social media
Electronic delivery address
AE:PL-15286-75439-ICARB-21

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 43.91kMedianUSD 38.31kAverageUSD 2.31m
Net profit
This companyUSD -1.56kMedianUSD -1.50kAverageUSD -84.98k
Operating costs
This companyUSD 33.63kMedianUSD 56.25kAverageUSD 2.29m
Assets
This companyUSD 81.71kMedianUSD 116.77kAverageUSD 2.72m

Bank accounts

Registered as a VAT taxpayer on 2020-06-24. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Wioletta Krakówka — Vice President of the Management Board
Piotr Roman Orłowski — President of the Management Board

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Wioletta Krakówka (49)
50$13,506.2150%
Piotr Roman Orłowski (41)
50$13,506.2150%

Beneficial owners

Person
Wioletta Krakówka (49)
Piotr Roman Orłowski (41)

Competitors

Name
AI Corelabsp. z o.o.
Countess Laboratoriessp. z o.o.
AM Lab Solutionssp. z o.o.
Xenstatssp. z o.o.
New Valuesp. z o.o.
Pominnosp. z o.o.
Biostat Research And Developmentsp. z o.o.
VB IdeaP.S.A.
CannamedaiS.A.
Medaisp. z o.o.

Change history

DateEvent
2024-02-14Address change
2024-02-14Share capital change
2020-05-05Address change
2020-05-05PKD change
2019-01-15Entered in the register

FAQ

Last updated: 2026-04-10